1 1

GLP-1 S (5mg) / SLU-PP-332 (1mg) x 30 Tablets

GLP-1 S (5mg) / SLU-PP-332 (1mg) x 30 Tablets

$605.00 USD
$750.00 USD $605.00 USD
Sale Sold out
Shipping calculated at checkout.
Product Image

GLP-1 S (5mg) / SLU-PP-332 (1mg) x 30 Tablets

$605.00 USD

  • FREE SHIPPING
  • 99+% PURITY
  • MADE IN USA
View full details

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

All articles, product descriptions, and information provided on this website are intended solely for informational and educational purposes. The products offered are strictly for in-vitro research and laboratory use only. "In-vitro" refers to studies conducted outside of the body, such as in a controlled laboratory setting (e.g., in glassware or test tubes). These products are not intended for human or animal consumption, and any bodily introduction is strictly prohibited by law. They are not medicines, drugs, or therapeutic treatments and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition. Misuse of these products is strictly against the law and company policy. Always handle these materials responsibly and in accordance with applicable regulations.

What is GLP-1 S (5mg) / SLU-PP-332 (1mg) x 30 Tablets?

GLP-1 S

GLP-1 S is a relatively short peptide hormone, comprising 30-31 amino acids, and is known for its role in naturally lowering blood sugar levels by enhancing insulin secretion in a glucose-dependent manner. Beyond its crucial function in glycemic control, GLP-1 S demonstrates multifaceted effects throughout the body. GLP-1 S has been explored for its potential benefits in various organs and systems.

Research indicates that GLP-1 S may not only be instrumental in managing diabetes by stimulating insulin and suppressing glucagon secretion but also in influencing broader aspects of health. Studies suggest that GLP-1 S may enhance heart, liver, and lung function. GLP-1 S has shown potential in slowing or preventing the accumulation of amyloid beta plaques pointing to its neuroprotective properties. Additionally, GLP-1 S has demonstrated an ability to significantly decrease appetite by delaying gastric emptying and reducing intestinal motility, making it relevant not only for diabetes treatment but also for potential applications in weight management. As research continues, GLP-1 S emerges as a multifunctional peptide with implications for various physiological processes and potential therapeutic avenues.

SLU-PP-332
SLU-PP-332 is a small-molecule compound classified as a REV-ERB agonist, a class of compounds that play a key role in regulating circadian rhythm, mitochondrial function, and lipid metabolism. By activating REV-ERBα and REV-ERBβ nuclear receptors, SLU-PP-332 helps shift the body toward increased fat burning and energy efficiency—making it a promising candidate in metabolic and endurance-related research.

Originally developed for its impact on circadian biology, SLU-PP-332 has shown the potential to enhance endurance, reduce fat storage, and improve metabolic homeostasis in preclinical models. Delivered in oral tablet form, it offers convenient access for researchers investigating fat loss, energy regulation, and mitochondrial performance.

Chemical Structure of Reta GLP-1 S (5mg) / SLU-PP-332 (1mg) x 30 Tablets

GLP-1 S, a glucagon-like peptide-1 analog, is a synthetic peptide with a specific amino acid sequence. The chemical structure and sequence of GLP-1 S are as follows:

HXEGTFTSDVSSYLEGQAAK-OH.steric diacid-EFIAWLVRGRG

SLU-PP-332 is a synthetic, non-peptide REV-ERB agonist targeting nuclear hormone receptors REV-ERBα and REV-ERBβ.

  • Chemical Type: Small-molecule compound
  • Mechanism: REV-ERBα/β receptor agonist
  • Pathways Influenced: Circadian rhythm, mitochondrial activity, lipid metabolism

(Note: SLU-PP-332 does not have a simple peptide sequence and is classified based on its molecular activity.)

What Are the Effects of GLP-1 S (5mg) / SLU-PP-332 (1mg) x 30 Tablets

GLP-1 S
Decreased Appetite

GLP-1 S, a glucagon-like peptide-1 analog, has been shown to significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. This effect on appetite regulation is particularly relevant in the context of weight management and obesity treatment. By slowing down the emptying of the stomach and influencing intestinal motility, GLP-1 S helps reduce appetite, thereby reducing overall caloric intake and contributing to weight loss.

Lowers Blood Sugar

One of the primary physiological functions of GLP-1 S analogs is to lower blood sugar levels. GLP-1 S enhances insulin secretion in a glucose-dependent manner, promoting better glucose control. By mimicking the actions of natural GLP-1 S, the analog contributes to improved glycemic management. The enhanced insulin secretion helps regulate blood sugar levels.

Lower Cardiovascular Risk

Beyond its direct impact on blood sugar levels, GLP-1 S has shown potential cardiovascular benefits. Research indicates that the GLP-1 S analog may improve heart function and reduce cardiovascular risk factors. Cardiovascular health is a critical aspect of overall well-being. GLP-1 S's positive effects on cardiovascular health contribute to its significance in the management of related complications.

Boosts Glycemic Control

GLP-1 S plays a crucial role in boosting glycemic control. By stimulating insulin secretion and suppressing glucagon secretion in a glucose-dependent manner, the GLP-1 S analog helps maintain a more balanced and controlled glucose profile. This contributes to better overall glycemic management, reducing the likelihood of glucose spikes and greater stability in blood sugar levels.

SLU-PP-322
Enhanced Fat Oxidation and Energy Expenditure

SLU-PP-332 boosts the body’s ability to burn fat for energy by increasing mitochondrial activity. It supports fat loss and improved energy utilization, making it highly relevant for research focused on obesity and metabolic disorders.

Circadian Rhythm Regulation

By acting on REV-ERBα/β, SLU-PP-332 helps synchronize the biological clock, influencing metabolism, hormone regulation, and sleep-wake cycles. This property positions it as a candidate for studies involving circadian rhythm disorders and metabolic syndrome.

Improved Endurance and Mitochondrial Performance

Studies suggest SLU-PP-332 enhances endurance and physical performance by optimizing mitochondrial function and muscle metabolism. This makes it valuable for researchers exploring energy balance and performance enhancement.

Support for Weight Loss and Metabolic Health

The compound’s multifaceted action on fat metabolism, energy balance, and circadian timing systems presents a powerful research pathway for weight management and metabolic optimization.